Smoking Significantly Increases Psoriasis Relapse Risk, reveals research
Researchers have established that smoking tobacco has a high likelihood of increasing the risk of relapse in patients receiving treatment for psoriasis. The study was recently published in the journal of Psoriasis by Shen F. and fellow researchers. The results indicate that smoking not only influences the severity and onset of psoriasis but also potentially has a central part in reducing the success of long-term treatment, highlighting the extreme significance of giving up smoking in the care of chronic skin disorders.
551 adult psoriasis patients participated in the study, 75.7% of whom were male with a mean age of 45.8 years. A formal observational design was used, with information assessed by standardized questionnaire and physical examination at baseline, week 12, week 24, and week 48. Improvement was quantified by PASI scores. PASI50 and PASI75 indicated 50% and 75% improvement, respectively, and relapse was identified by the loss of at least 50% of this improvement after week 12. 282 out of the total participants were current smokers (51.2%). Researchers took special notice of the presence of smoking behavior and its level, which was measured through daily cigarette consumption and smoking duration.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.